Sentence examples for rebounding development of from inspiring English sources

Can they bank on the rebounding development of Ibaka, who has shown promise in his first three N.B.A. seasons?

Antiretroviral adherence studies indicate that greater than 95% adherence to ARV therapy provides optimal efficacy while limiting viral rebound and development of HIV drug resistance, although at least 80% adherence has been used conventionally in non-HIV medication adherence studies (Bangsberg et al 2000; Paterson et al 2000; Gross et al 2001; Maggiolo et al 2005).

After the tumultuous Great Depression of the 1930s, Omaha rebounded with the development of Offutt Air Force Base just south of the city.

These results suggest that limited numbers of activated T cells at viral rebound and subsequent development of broadly reactive cell-mediated responses may be interrelated in reducing the viral reservoir.The HIV reservoir in CD4+ T cells represents one main obstacle to HIV eradication.

Seventy-two hours after the accident the child was normothermic without development of rebound hyperthermia.

As a result, the patient may experience rebound in viral load or the development of viral resistance.

60, 61 HIV-positive persons may refuse ART or reduce treatment compliance as a result of or in order to avoid the side effects, and as a result, they may experience rebound in viral load or the development of viral resistance, which could consequently lead to disease progression and even to an increased risk of disease transmission, probably by a drug-resistant viral strain.

Second, prevention of malaria through chemoprevention may impede the development of immunity, leading to rebound morbidity after completion of the intervention, although rebound after chemoprevention has generally either not been seen, or been modest [ 28], and it would likely be of less importance in schoolchildren than younger children.

Real-time adherence monitoring could allow for the detection of adherence lapses and interventions to resume treatment prior to the development of virologic rebound and drug resistance, which has not previously been possible [ 3].

Additionally, before discontinuing TDF it is also necessary to know whether a patient is HBsAg positive because such patients would require an additional anti-HBV agent such as entecavir to prevent HBV rebound, hepatitis flare, and the development of HBV resistance to 3TC and FTC [ 1].

It is a similar story in the rebounding global property development industry.